Akribion Therapeutics is a startup based in the United States, most recent round Series A.
Akribion Therapeutics is a company founded in 2015 headquartered in the United States. Its most recent tracked round is Series A.
Akribion Therapeutics is a biotechnology company developing novel therapies for neurodegenerative diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.